SCHEMBL5865322

SCHEMBL5865322

Cc1ccc(/C=C/c2cccc(N)n2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 6/20 0.71
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 4/20 0.51
HPGD P15428 4/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2C19 P33261 3/20 0.51
HDAC6 Q9UBN7 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
CYP2D6 P10635 2/20 0.51
GRM5 P41594 1/20 0.51
MEN1 O00255 1/20 0.51
CYP3A4 P08684 1/20 0.51
PKM P14618 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51
THPO P40225 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865325 1.00 GRM4 (0.71) GRM4ALDH1A1KDM4EHPGDNPC1
Hydrochloric Acid SCHEMBL5864853 0.98 GRM4 (0.69) GRM4ALDH1A1KDM4EHPGDNPC1
Hydrochloric Acid SCHEMBL5864859 0.98 GRM4 (0.69) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5864826 0.83 GRM4 (1.00) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5864824 0.83 GRM4 (1.00) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5865492 0.82 GRM4 (0.71) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5865349 0.82 GRM4 (0.71) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5865491 0.82 GRM4 (0.71) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5864956 0.82 GRM4 (0.71) GRM4ALDH1A1KDM4EHPGDNPC1
SCHEMBL5865353 0.82 GRM4 (0.71) GRM4ALDH1A1KDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C GRM4 20/4885ALDH1A1 832/4885KDM4E 1020/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C GRM4 20/4885ALDH1A1 832/4885KDM4E 1020/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C GRM4 19/4885ALDH1A1 1046/4885KDM4E 925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.